Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2003
08/13/2003EP1334717A2 Pharmaceutical Compositions For Oral And Topical Administration
08/13/2003EP1334358A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease
08/13/2003EP1334201A2 Dna expression vectors
08/13/2003EP1334188A2 Cd19-specific redirected immune cells
08/13/2003EP1334186A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
08/13/2003EP1334118A2 Methods and reagents for regulation of cellular responses in biological systems
08/13/2003EP1334089A1 Quinoline derivatives as nk-3 and nk-2 antagonists
08/13/2003EP1334088A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
08/13/2003EP1334086A1 Phenoxyphenyl alkane sulfonates
08/13/2003EP1333859A2 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network
08/13/2003EP1333853A1 Growth factor complex
08/13/2003EP1333852A2 Agents for reducing graft rejection reactions
08/13/2003EP1333851A1 Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities
08/13/2003EP1333850A2 Method and composition for inhibition of tumor growth and enhancing an immune response
08/13/2003EP1333845A1 Treatment of t cell disorders
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333839A1 Method for the treatment of inflammation
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1333810A2 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
08/13/2003EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists
08/13/2003EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors
08/13/2003EP1220845B1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors
08/13/2003EP1163008B1 Use of trehalose for stabilising a liquid vaccine
08/13/2003EP1158990A4 Administration of an anti-endotoxin drug by intravenous infusion
08/13/2003EP1147108B1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
08/13/2003EP1143942B1 Use of gaba-b receptor ligands for the manufacture of medicaments for the treatment of neurodegenerative diseases
08/13/2003EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
08/13/2003EP1066060B1 Mesenchymal stem cells as immunosuppressants
08/13/2003EP0814809B1 Aryl thioxanthines
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003EP0588859B1 Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use
08/13/2003CN1436235A Anti-angiogenic polypeptides
08/13/2003CN1436234A Composition and methods for therapy and diagnosis of prostate cancer
08/13/2003CN1436188A 1,3,8-triaza-spiroÒÇö4,5ÒÇòdecan-4-one derivs. as neurokinin receptor antagonists
08/13/2003CN1436180A Diamino phenothiazine derivs. and composition comprising same
08/13/2003CN1436168A Beta-amino acid nitrile derivs.
08/13/2003CN1436086A Interferon for treatment of multiple sclerosis
08/13/2003CN1436084A Remedies for allergic diseases and process for producing same
08/13/2003CN1435433A Long-acting broad-spectrum chemotactic factor receptor inhibiting matter
08/13/2003CN1435423A Aromatic pyranocarbonosides and preparing process thereof
08/13/2003CN1435422A Unsaturated pyranocarbonoside compounds and preparing process thereof
08/13/2003CN1435253A Health-care product contg. slime bacteria sporocarp for strengthening immunity and preparing process thereof
08/13/2003CN1435252A Ant powder dietetic preparation as broad-spectrum immunity strengthening agent and preparing method thereof
08/13/2003CN1435185A Cell growth regulatory factor A and preparing process thereof
08/13/2003CN1435184A Cell growth regulatory factor C and preparing process thereof
08/13/2003CN1435183A Cell growth regulatory factor L and preparing process thereof
08/13/2003CN1435182A Cell growth regulatory factor N and preparing process thereof
08/13/2003CN1435180A Gypenoside drip pill, and preparing process thereof
08/13/2003CN1435179A Biologic converted ginseng composition and preparing process thereof
08/13/2003CN1117744C 1-(1,2-disubstd. piperidinyl)-4-substd. piperazine derivs.
08/13/2003CN1117566C Combination therapy comprising amlodipine and statin compound
08/12/2003US6605742 Rheumatic diseases; antiarthritic agents; antitumor agents
08/12/2003US6605722 Tyrosine derivatives with anti-leukotrienen activity
08/12/2003US6605702 Protein for use in the treatment of inflammatory defects and asthma
08/12/2003US6605639 Treating and/or preventing diseases alleviated by retinoid X receptor ligand dependent transcriptional regulation using ascochlorin or derivatives
08/12/2003US6605637 Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid
08/12/2003US6605616 Autoimmune diseases; inflammation
08/12/2003US6605613 Polyene macrolide antibiotic, especially a rapamycin, and an antioxidant, especially 2,6-di-t-butyl-4-methylphenol; 40-O-(2-hydroxy)ethyl-rapamycin in crystalline form.
08/12/2003US6605593 Enhanced efficacy and reduced toxicity
08/12/2003US6605592 Protein HOFNF53
08/12/2003US6605591 Treatment of subnormal bone mineral density
08/12/2003US6605426 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
08/12/2003US6605286 Delivery of biologically active polypeptides
08/12/2003US6605279 Nucleotide sequences coding preferential polypeptide for use in intensifying immunological response
08/12/2003CA2286126C Pharmaceutical compositions
08/12/2003CA2248653C Vaccines for treatment of lymphoma and leukemia
08/12/2003CA2212836C Substituted isoxazoles for the treatment of inflammation
08/08/2003WO2002060922A2 Epoxyvibsanin b
08/08/2003CA2458220A1 Epoxyvibsanin b
08/07/2003WO2003065046A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
08/07/2003WO2003064685A2 Genetic polymorphisms in the preprotachykinin gene
08/07/2003WO2003064662A1 Bispecific molecules cross-linking itim and itam for therapy of allergies
08/07/2003WO2003064632A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064626A2 Double-stranded oligonucleotides
08/07/2003WO2003064625A2 Oligonucleotide compositions with enhanced efficiency
08/07/2003WO2003064622A2 Aggrecanase molecules
08/07/2003WO2003064472A2 Treatment of ms with goat serum
08/07/2003WO2003064458A2 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
08/07/2003WO2003064457A1 A method for inhibiting 'melanoma inhibitory activity' mia
08/07/2003WO2003064447A2 Immune-modulating peptide
08/07/2003WO2003064443A2 New corticosteroids
08/07/2003WO2003064439A2 Sialic carbohydrates
08/07/2003WO2003064425A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/07/2003WO2003064419A1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
08/07/2003WO2003064411A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064383A2 Phosphorus-containing compounds & uses thereof
08/07/2003WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003WO2003063906A1 Drugs for treating inflammatory diseases
08/07/2003WO2003063905A1 Preventives or remedies for immunological diseases
08/07/2003WO2003063871A1 Phenylpyrimidine amines as ige inhibitors
08/07/2003WO2003063850A1 Medicinal compositions containing vitamin k’s as nerve growth factor potentiator and utilization thereof
08/07/2003WO2003063800A2 8-heteroaryl xanthine adenosine a2b receptor antagonists
08/07/2003WO2003063794A2 2,4-pyrimidinediamine compounds and their uses
08/07/2003WO2003063766A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003WO2003063758A2 Bicyclic cb2 cannabinoid receptor ligands
1 ... 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 ... 1172